Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,079 | 119 | 37.5% |
| Consulting Fee | $3,500 | 1 | 32.2% |
| Honoraria | $1,770 | 1 | 16.3% |
| Travel and Lodging | $1,460 | 1 | 13.4% |
| Education | $70.21 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Outset Medical Inc | $5,925 | 6 | $0 (2023) |
| Horizon Therapeutics plc | $2,092 | 14 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $848.12 | 34 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $374.34 | 12 | $0 (2024) |
| BARD PERIPHERAL VASCULAR, INC. | $295.05 | 3 | $0 (2019) |
| Relypsa, Inc. | $276.55 | 16 | $0 (2019) |
| Teleflex LLC | $179.33 | 2 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $119.96 | 6 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $118.36 | 4 | $0 (2020) |
| Abbott Laboratories | $115.05 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $782.95 | 28 | AKEBIA THERAPEUTICS INC ($285.14) |
| 2023 | $5,733 | 13 | Outset Medical Inc ($5,467) |
| 2022 | $730.11 | 14 | Outset Medical Inc ($298.87) |
| 2021 | $327.46 | 13 | AstraZeneca Pharmaceuticals LP ($192.09) |
| 2020 | $2,068 | 9 | Horizon Therapeutics plc ($1,817) |
| 2019 | $639.49 | 28 | Horizon Therapeutics plc ($228.17) |
| 2018 | $316.38 | 16 | Relypsa, Inc. ($150.25) |
| 2017 | $281.61 | 3 | Bard Peripheral Vascular, Inc. ($264.49) |
All Payment Transactions
124 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $9.01 | General |
| Category: Nephrology | ||||||
| 12/11/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Nephrology | ||||||
| 12/10/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $30.79 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/20/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Nephrology | ||||||
| 09/25/2024 | AKEBIA THERAPEUTICS INC | — | Food and Beverage | In-kind items and services | $146.20 | General |
| 09/18/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $31.73 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 09/05/2024 | Teleflex LLC | Titan SGS (Device) | Food and Beverage | In-kind items and services | $75.35 | General |
| Category: SURGICAL | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Immunology | ||||||
| 09/03/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/20/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: Nephrology | ||||||
| 07/16/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $75.35 | General |
| Category: Nephrology | ||||||
| 07/03/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.55 | General |
| 06/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $8.07 | General |
| Category: Nephrology | ||||||
| 05/22/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.49 | General |
| 04/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/03/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $22.76 | General |
| 03/20/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Nephrology | ||||||
| 03/06/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.61 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 684 | 1,624 | $458,503 | $194,651 |
| 2022 | 10 | 790 | 2,042 | $536,776 | $224,851 |
| 2021 | 12 | 840 | 2,111 | $571,730 | $250,068 |
| 2020 | 12 | 982 | 2,573 | $762,987 | $302,842 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 52 | 356 | $166,252 | $77,945 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 179 | 433 | $89,198 | $38,590 | 43.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 154 | 190 | $75,240 | $24,277 | 32.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 106 | 259 | $52,577 | $23,328 | 44.4% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 36 | 60 | $21,540 | $8,989 | 41.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 62 | 133 | $18,753 | $8,010 | 42.7% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 32 | 129 | $18,447 | $7,058 | 38.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 48 | 48 | $15,264 | $5,847 | 38.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 15 | 16 | $1,232 | $606.88 | 49.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 208 | 539 | $111,034 | $48,053 | 43.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 48 | 199 | $92,933 | $43,392 | 46.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 171 | 231 | $91,476 | $34,804 | 38.0% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 50 | 178 | $63,902 | $26,229 | 41.0% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 13 | 92 | $42,872 | $21,096 | 49.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 53 | 301 | $43,043 | $16,860 | 39.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 81 | 204 | $41,412 | $15,956 | 38.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 92 | 221 | $31,161 | $11,947 | 38.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 54 | 54 | $17,172 | $5,839 | 34.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 20 | 23 | $1,771 | $675.82 | 38.2% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 55 | 295 | $137,765 | $68,183 | 49.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 190 | 431 | $88,786 | $40,213 | 45.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 161 | 237 | $93,852 | $35,501 | 37.8% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 53 | 410 | $58,630 | $22,943 | 39.1% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 42 | 71 | $39,405 | $18,771 | 47.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 70 | 197 | $39,991 | $15,747 | 39.4% |
About Dr. Dave Khurana, MD
Dr. Dave Khurana, MD is a Nephrology healthcare provider based in Huntsville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700945250.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dave Khurana, MD has received a total of $10,879 in payments from pharmaceutical and medical device companies, with $782.95 received in 2024. These payments were reported across 124 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($4,079).
As a Medicare-enrolled provider, Khurana has provided services to 3,296 Medicare beneficiaries, totaling 8,350 services with total Medicare billing of $972,412. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Huntsville, TX
- Active Since 12/08/2006
- Last Updated 08/14/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700945250
Products in Payments
- KRYSTEXXA (Biological) $2,074
- LOKELMA (Drug) $566.31
- Veltassa (Drug) $324.76
- FARXIGA (Drug) $266.97
- BPV-Lutonix (Device) $264.49
- Auryxia (Drug) $201.36
- ACTHAR (Biological) $186.21
- PROCLAIM (Device) $115.05
- DEKNATEL (Device) $103.98
- Vafseo (Drug) $100.28
- SAMSCA (Drug) $82.10
- Titan SGS (Device) $75.35
- PURIFIED CORTROPHIN GEL (Drug) $62.52
- TARPEYO (Drug) $59.99
- JYNARQUE (Drug) $36.26
- Velphoro (Drug) $32.38
- AVYCAZ (Drug) $30.71
- Parsabiv (Biological) $27.51
- Fabhalta (Drug) $22.22
- FABRAZYME (Biological) $18.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Huntsville
Michael Quadrini, M.d, M.D
Nephrology — Payments: $633,700
James Smelser, M. D, M. D
Nephrology — Payments: $36,445
Sayed Tabatabai, M.d, M.D
Nephrology — Payments: $7,455
Dr. Todd Broome, Md, MD
Nephrology — Payments: $6,979
Dr. David Tietjen, Md, MD
Nephrology — Payments: $5,751
Elisabeth Owen, Crnp, CRNP
Nephrology — Payments: $4,691